Akums Drugs and Pharma climbs after strong Q2 earnings
Mumbai, Nov. 3 -- Revenue from operations climbed 31.93% YoY to Rs 1342.38 crore in Q2 FY27.
Profit before tax (PBT) soared 135.63% YoY to Rs 154.74 crore in Q2 FY27. The company's EBITDA surged 106% YoY to Rs 195 crore compared with Rs 94 crore in the corresponding quarter last year. EBITDA margin expanded to 14.5% from 9.3%.
The CDMO business remained the key growth driver, with revenue increasing 38.6% YoY to Rs 1,115 crore from Rs 804 crore. CDMO EBITDA nearly doubled to Rs 168 crore from Rs 84 crore, supported by healthy double-digit volume growth and sustained demand.
For the first half of FY27, the company's consolidated net profit surged 104.18% YoY to Rs 212.86 crore in H1 FY27, revenue from operations increased 22.9% to Rs 2,...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.